Relenza - Proven Continued Effectiveness Against Influenza Worldwide

Relenza - Proven Continued Effectiveness Against Influenza Worldwide

322 Reads 0 Votes 1 Part Story
gpharma By gpharma Updated Oct 30, 2009

Relenza, Proven Continued Effectiveness Against Influenza Worldwide.

Relenza (Zanamivir, INN) is a safe and effective antiviral agent with well  cited proven effectiveness and safety in the treatment and prevention of Influenza A and Influenza B infection and which belongs to a small class of drugs known as Neuraminidase Inhibitors  (1, 2, 3, 4).

Relenza's unique nature and pharmacological characteristics, particularly in light of the current world influenza pandemic, have demonstrated its utility and effectiveness in the treatment and combating the spread of influenza in populations throughout the world. In the absence of a safe and effective vaccine, strategies to curtail the spread and impact of Influenza, worldwide, have relied heavily on anti-influenza drugs with Neuraminidase Inhibitors, by far, the agents of choice and helped ensure we are not powerless the face of a world flu threat (5, 6, 7, 8).

Descriptions of Influenza have been documented since antiquity. However, it has...

  • avian
  • flu
  • flue
  • health
  • neuraminidase
  • relenza
  • sars
  • swine
  • zanamivir